[HTML][HTML] Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches

M Tufail, J Cui, C Wu - American journal of cancer research, 2022 - ncbi.nlm.nih.gov
Breast cancer (BC) affects over 250,000 women in the US each year. Drug-resistant cancer
cells are responsible for most breast cancer fatalities. Scientists are developing novel …

Shedding light on the dark genome: Insights into the genetic, CRISPR-based, and pharmacological dependencies of human cancers and disease aggressiveness

D Kafita, P Nkhoma, K Dzobo, M Sinkala - Plos one, 2023 - journals.plos.org
Investigating the human genome is vital for identifying risk factors and devising effective
therapies to combat genetic disorders and cancer. Despite the extensive knowledge of the" …

RANK pathway in cancer: underlying resistance and therapeutic approaches

M Tufail, C Wu - Journal of Chemotherapy, 2023 - Taylor & Francis
Cancer remains one of the deadliest diseases despite advances in treatment. Metastatic
cancers are the leading cause of death for advanced cancer patients. Those with advanced …